KELLY PEARSON: Open Payments
NPI 1124216882 · WINDSOR HEIGHTS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 42 payments from 7 companies in 2025. Trend: 2023 $373 · 2024 $393 · 2025 $618
Food & beverage: $610Education: $8
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $242 |
| GENZYME CORPORATION | 18 | $191 |
| GlaxoSmithKline, LLC. | 4 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $31 |
| Genentech USA, Inc. | 1 | $20 |
| Jubilant HollisterStier LLC | 1 | $18 |
Products named: DUPIXENT, FASENRA, NUCALA, XOLAIR, TEZSPIRE, BREZTRI, NEFFY, Rhapsido.
Industry payments across IA — which companies pay providers there.
